Publicaciones en colaboración con investigadores/as de Oslo University Hospital (10)

2024

  1. Distinct spatial landscapes in clear-cell renal cell carcinoma as revealed by whole transcriptome analysis

    Immuno-Oncology and Technology, Vol. 21

2021

  1. (Pro)renin receptor is a novel independent prognostic marker in invasive urothelial carcinoma of the bladder

    Cancers, Vol. 13, Núm. 22

2019

  1. A Critical Insight into the Clinical Translation of PD-1/PD-L1 Blockade Therapy in Clear Cell Renal Cell Carcinoma

    Current Urology Reports, Vol. 20, Núm. 1

  2. Precise definition of PTEN C-terminal epitopes and its implications in clinical oncology

    npj Precision Oncology, Vol. 3, Núm. 1

  3. Precise immunodetection of PTEN protein in human neoplasia

    Cold Spring Harbor Perspectives in Medicine, Vol. 9, Núm. 12

  4. The coexpression of fibroblast activation protein (FAP) and basal-type markers (CK 5/6 and CD44) predicts prognosis in high-grade invasive urothelial carcinoma of the bladder

    Human Pathology, Vol. 91, pp. 61-68

2018

  1. Correction to: Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE study (Intensive Care Medicine, (2016), 42, 12, (1865-1876), 10.1007/s00134-016-4571-5)

    Intensive Care Medicine

  2. Immunocompromised patients with acute respiratory distress syndrome: Secondary analysis of the LUNG SAFE database

    Critical Care, Vol. 22, Núm. 1

2017

  1. Geo-economic variations in epidemiology, patterns of care, and outcomes in patients with acute respiratory distress syndrome: insights from the LUNG SAFE prospective cohort study

    The Lancet Respiratory Medicine, Vol. 5, Núm. 8, pp. 627-638

2016

  1. The expression of fibroblast activation protein in clear cell renal cell carcinomas is associated with synchronous lymph node metastases

    PLoS ONE, Vol. 11, Núm. 12